Vericel Corp — Director's Dealing 2013

Aug 27, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2013-08-23

Reporting Person: Elliston Michael W. (Controller)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.86	2021-12-20	Common Stock (100000)		Direct
Stock Option (right to buy)	$2.49	2022-05-03	Common Stock (50000)		Direct

Footnotes

F1: These options were granted on December 20, 2011 with 25% vesting on the first anniversary of the date of grant and 6.25% vesting each quarter thereafter.

F2: These options were granted on May 3, 2012 and vest quarterly over four years commencing on the date of grant.